Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Puma Biotech: Q4 Earnings Snapshot

Puma Biotech: Q4 Earnings Snapshot

PBYI : 4.88 (+1.04%)
Puma Biotech: Q3 Earnings Snapshot

Puma Biotech: Q3 Earnings Snapshot

PBYI : 4.88 (+1.04%)
Puma Biotech: Q2 Earnings Snapshot

Puma Biotech: Q2 Earnings Snapshot

PBYI : 4.88 (+1.04%)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 724.87 (-1.00%)
PBYI : 4.88 (+1.04%)
GILD : 65.27 (-2.70%)
IMGN : 31.23 (unch)
BCTX : 2.24 (+2.28%)
BCT.TO : 3.01 (+0.33%)
There are Positive Developments in the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is desperately needed in the fight against metastatic breast cancer. As it stands right now, metastatic breast cancer has no cure and has proven resistant to many cancer...

LLY : 724.87 (-1.00%)
PBYI : 4.88 (+1.04%)
GILD : 65.27 (-2.70%)
IMGN : 31.23 (unch)
BCTX : 2.24 (+2.28%)
BCT.TO : 3.01 (+0.33%)
Five Impressive Metastatic Cancer Treatment Stocks to Own Today

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone...

LLY : 724.87 (-1.00%)
PBYI : 4.88 (+1.04%)
GILD : 65.27 (-2.70%)
IMGN : 31.23 (unch)
BCTX : 2.24 (+2.28%)
BCT.TO : 3.01 (+0.33%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 1, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 4.88 (+1.04%)
Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Rise Y/Y

Puma Biotechnology (PBYI) earnings and sales beat estimates in Q1. Stock rises in after-hours.

PBYI : 4.88 (+1.04%)
RCUS : 14.73 (-4.54%)
ALLO : 2.86 (-6.09%)
OCUP : 1.5350 (+0.33%)
Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates

Puma Biotech (PBYI) delivered earnings and revenue surprises of 550% and 6.22%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PBYI : 4.88 (+1.04%)
LCTX : 1.1100 (+0.91%)
Puma Biotech: Q1 Earnings Snapshot

Puma Biotech: Q1 Earnings Snapshot

PBYI : 4.88 (+1.04%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar